International Journal of Gynecology and Obstetrics

Aesop technique
pp. 1-1(1)
Author: Mettler L.

Lahystotrain - integration of virtual environments and intelligent training systems for laparoscopy and hysteroscopy
pp. 1-1(1)
Authors: Oppelt P.; Stahler J.; Miller W.; Kaufmann M.

Mid-trimester loss
pp. 1-1(1)
Author: Senanayake H.

Obstetric management and reproductive outcome after hysteroscopic metroplasty
pp. 1-1(1)
Authors: Ferrazzi E.; Leone F.P.G.; Ragusa G.; Lanzani C.; Bulfoni A.; Pardi G.

Role of ultrasound in cervical assessment
pp. 2-2(1)
Author: Song T.-B.

Endometrial factors in recurrent miscarriage
pp. 2-2(1)
Author: Stephenson M.D.

Fetal cells in cervical mucus
pp. 2-2(1)
Author: Rodeck C.H.

Fluorescence in situ hybridization
pp. 2-2(1)
Author: uzumori K.

Management of low grade smears
pp. 2-3(2)
Authors: Chen H.S.; Yang Y.C.; Su T.H.

HPV as a form of risk assessment
pp. 3-3(1)
Author: Kitchener H.

Current surgical management of cervical cancer
pp. 3-3(1)
Author: Sardi J.E.

Place of conservative surgery in cervical cancer
pp. 3-3(1)
Authors: Schneider A.; Possover M.

Concomitant chemoradiation
pp. 3-3(1)
Author: Trimble E.L.

Role of pathology in determining management of vulval cancer
pp. 4-4(1)
Author: Kaufman R.

Primary surgery for vulval cancer
pp. 4-4(1)
Author: Bender H.G.

Management of recurrent vulvar cancer
pp. 4-4(1)
Author: Lindeoue B.G.

Endometriosis and infertility
pp. 4-4(1)
Author: Shaw R.W.

Endometriosis and pain
pp. 4-4(1)
Author: Bontis J.N.

Prevention of unwanted teenage pregnancy: The dutch experience
pp. 5-5(1)
Author: Van Lunsen R.H.W.

Factors that influence attitudes
pp. 5-5(1)
Author: Milsom I.

Conflict in interpreting screening tests
pp. 5-5(1)
Author: Grimes D.A.

Conflict in interpreting randomized trial - The example of fetal heart rate monitoring
pp. 5-5(1)
Author: Kuenzel W.

Challenges we face and resolution of conflicts in the developing world
pp. 6-6(1)
Author: Rizvi J.

Teaching the art of medicine
pp. 6-6(1)
Author: Mc Lain C.R.

Opportunities in international eduation in obstetrics and gynecology
pp. 6-7(2)
Author: Sciarra J.J.

A national program to teach teachers to teach
pp. 7-7(1)
Author: Herbert W.N.P.

Terapia reemplazo hormonal y cancer de mama
pp. 7-7(1)
Author: Jorge Tisne T.

Urogenital aging
pp. 7-7(1)
Author: Contreras Ortiz O.

From urogynecology to perineology
pp. 7-8(2)
Author: Mouchel J.

Perineology: Definition and principles
pp. 8-8(1)
Author: Beco J.

Practical perineology: Examples
pp. 8-8(1)
Authors: Beco J.; Mouchel J.

Maternal mortality - An overview
pp. 8-8(1)
Author: Liljestrand J.

Preterm birth and perinatal brain damage
pp. 8-8(1)
Author: Ohlsson A.

Cerebral palsy - medico-legal issues
pp. 9-9(1)
Author: MacLennan A.H.

Screening for familial ovarian cancer
pp. 9-9(1)
Author: Karlan B.Y.

Early detection of ovarian cancer: Methodological considerations
pp. 9-9(1)
Author: Urban N.

Treatment of cin: burn freeze or cut?
pp. 9-10(2)
Author: Flannelly G.

Vaccines against cervical neoplasia
pp. 10-10(1)
Author: Paavonen J.

Follow-up after treatment
pp. 10-10(1)
Author: Lou Benedet J.

What is optimal surgery for endometrial cancer?
pp. 10-10(1)
Author: Quinn M.

Management of sarcomas
pp. 10-11(2)
Author: Scollo P.

The case for regulation
pp. 11-11(1)
Author: Lieberman B.A.

Regulation of fertility treatment and research
pp. 11-11(1)
Author: Aboulghar M.

An overview of uterine receptivity
pp. 11-11(1)
Authors: Cooke I.D.; Lim K.

IGF system
pp. 11-12(2)
Author: Gazvani M.R.

Integrins as markers of endometrial receptivity
pp. 12-12(1)
Author: Lessee B.A.

Introduction to the session
pp. 12-12(1)
Author: Manguvu F.

The future role of health ministries
pp. 12-12(1)
Author: Brookman-Amissah E.

The role of professional organizations
pp. 12-12(1)
Author: Okonofua F.

The view from the obgyn in rural practice
pp. 13-13(1)
Author: Mbaruku G.

Campaigning for women's sexual and reproductive rights
pp. 13-13(1)
Author: Hlatshwayo Z.

Taking the teaching of ob/gyn surgical skills into the laboratory
pp. 13-13(1)
Authors: Kung R.; Allen L.

The K.O.A.L.A. program: An internet-based learning portfolio for residents
pp. 13-14(2)
Author: Fun Kee Fung M.

Depistage du cancer du col uterin dans les pays en developpement: Possible, raisonnable?
pp. 14-14(1)
Author: Guillon B.

The cultural and social consequences of exporting technology and knowledge
pp. 14-14(1)
Author: Kousmine S.

La mortalite maternelle: Espoirs d'une reduction de la frequence?
pp. 14-14(1)
Author: Philippe P.H.-J.

Pathophysiology of endometrial function
pp. 14-14(1)
Author: Critchley H.O.

Drug therapy
pp. 14-15(2)
Author: Tank D.

Intrauterine system
pp. 15-15(1)
Authors: Rutanen E.-M.; Hurskainen R.

Variations in surgical treatment
pp. 15-15(1)
Author: Rock J.A.

Genetic causes are responsible for most first trimester pregnancy losses
pp. 15-15(1)
Author: Simpson J.L.

Thrombophilia: An exaggerated prothrombotic response to pregnancy underlies many cases of recurrent pregnancy loss
pp. 15-16(2)
Author: Regan L.

Immunological aspects of recurrent miscarriage
pp. 16-16(1)
Author: Carp H.J.A.

Psychological aspects
pp. 16-16(1)
Author: Stray-Pedersen B.

Fetal growth restriction: A survival process but with increased risk for perinatal morbidity/mortality and longer term illness
pp. 16-17(2)
Author: Richardson B.S.

Investigation and prediction of fetal growth restriction
pp. 17-17(1)
Author: Odendaal H.

How do pathological risk factors affect outcome?
pp. 17-17(1)
Authors: van Dam P.A.; Verkinderen L.; Dirix L.Y.

The pathophysiologic character and tumor formation of human ovarian surface epithelial cells in ovarian epithelial carcinogenesis
pp. 17-17(1)
Authors: Katabuchi H.; Okamura H.

How does pathology influence management - germ cell tumours
pp. 17-18(2)
Author: Wong F.

Fertility management
pp. 18-18(1)
Authors: Genazzani A.R.; Cristello F.; Taponeco F.; D'Ambrogio G.; Artini P.G.

Preimplantation genetic diagnosis
pp. 18-18(1)
Author: Braude P.

Preimplantation genetic diagnosis and cytogenetic analysis for infertile males
pp. 18-18(1)
Author: Kubo H.

Preimplantation genetic diagnosis: Ethical considerations
pp. 18-18(1)
Authors: Diedrich K.; Ludwig M.

Experiences of the pmm network in west Africa
pp. 19-19(1)
Author: Kamara A.

Save the mothers fund project: Country projects
pp. 19-19(1)
Author: Lalondet A.B.

Guidelines, training materials and monitoring tools (WHO)
pp. 19-19(1)
Author: Liljestrand J.

Premature rupture of the membranes (prom) at less than 28 weeks of gestation - efficacy of fibrine sealing and double shirodkar's procedure
pp. 20-20(1)
Authors: Oura K.; Maitoko K.; Kimura E.; Ochiai K.; Tanaka T.

Umbilical tape for cervical cerclage
pp. 20-20(1)
Author: Nagarseker U.L.

Transvaginal ultrasonography in detection of cervical incompetency
pp. 20-20(1)
Authors: Podobnik M.; Podgajski M.; Gebauer B.

Plasma prostaglandin concentration after cervical cerclage and after transvaginal ultrasound examination during pregnancy
pp. 20-20(1)
Author: Jamal H.S.

Assessment of efficiency the reconstruction of the uterine orifice of cervix beyond the pregnancy
pp. 20-21(2)
Authors: Brzozowska M.; Lipecka-Kidawska E.; Kazimierak W.; Pajszczyk-Kieszkiewicz T.

Cervical length measurement and preterm delivery
pp. 21-21(1)
Authors: Hoesli I.; Daly-Grandeau E.; Ledermann S.; Tercanli S.; Holzgreve W.

Evaluation of risk for preterm delivery by fetal fibronectin and transvaginal ultrasonographic measurement of cervical length
pp. 21-21(1)
Authors: Oliveira T.A.; Souza E.; Carvalho C.M.P.; Mariani-Neto C.; Camano L.

Evaluation of cervical incompetence during pregnancy using transvaginal ultrasound examination with transfundal pressure
pp. 21-21(1)
Authors: Makhlouf A.; Sabra A.; Flamed E.; Flamed G.; Zahran K.

Application of nested pcr for the detection of chlamydia trachomatis in diagnosing and monitoring the patients with pelvic inflammatory disease and vaginitis
pp. 21-22(2)
Authors: Choi K.T.; Bae D.H.; Cho S.R.

Chlamydia trachomatis and spontaneous abortion
pp. 22-22(1)
Authors: Vigil P.; Zacharias S.; Tapia A.; Riquelme R.; Varleta J.

The condition of microbiocenosis of the sexual organs in patients with chlamydia infection
pp. 22-22(1)
Authors: Sevostyanova T.V.; Chaika V.K.; Iotenko B.A.

The peculiarities of current of genital inflammatory process in sexually active adolescents and women of fertile age
pp. 22-22(1)
Authors: Rudenko A.; Romashchenko O.; Romanenko A.; Spivak M.; Yakovenko L.; Shalkovsky E.

Reproductive tract infection, symptoms and syndromic management in rural gambian women
pp. 22-23(2)
Authors: Bailey R.; Coleman R.; West B.; Morison L.; Walraven G.

An assessment of diagnostic tests for the detection of asymptomatic Chlamydia trachomatis-A systematic review
pp. 23-23(1)
Authors: Honev E.J.; Russell I.T.; Templeton A.A.

Detection of chlamydia trachomatis intrauterine infection by using chorionic villous sampling and polymerase chain reaction
pp. 23-23(1)
Authors: Done Z.W.; Zhou S.Y.; Liu R.M.

Chlamydia trachomatis and habitual abortions. Is there any relation?
pp. 23-23(1)
Authors: Bogavac M.; Milosevic S.; Pavlov-Markovic M.; Mrdja E.; Jovanovic-Privrodski J.; Radulovic A.

Reassessing risk assessment in predicting chlamydia rachomatis genital infections in adolescent females
pp. 23-23(1)
Authors: Markovic A.; Sedlecki K.; Markovic L.; Markovic M.; Rajin G.

Vaginal endometriosis management
pp. 24-24(1)
Authors: Tosson S.; Hassan I.

Gonadotropin-releasing hormone agonist plus 'add-back' for the treatment of endometriosis. A prospective, randomized, placebo controlled, double blind trial
pp. 24-24(1)
Authors: Franke H.R.; van der Weijer P.H.M.; Pennings T.M.M.; van der Mooren M.J.

Safety and efficacy profile of a high dose treatment of endometriosis with 20 mg dienogest per day
pp. 24-24(1)
Authors: Moore C.; Schindler A.E.; Muller A.; Christensen B.

Treatment of endometriosis and infertility by long acting gonadotropin releasing hormone analog solely vs long acting gonadotropin releasing hormone analog with prednisolone
pp. 24-24(1)
Author: Colakoelu M.

Role of lowdose oral contraception in treatment of endometriosis
pp. 25-25(1)
Author: Bendova M.

Estrogen &unknown;add-back&unknown; and some menopausal changes associated with GnRHa therapy
pp. 25-25(1)
Authors: Al-Omari W.R.; Nassir U.N.; Izat B.; Sulaiman W.R.

Effectiveness of long term GN-RH agonist administration for treatment of endometriosis combined with estrogen-progestogen add back therapy
pp. 25-25(1)
Authors: Aisaka K.; Nakagawa K.; Uesato T.; Miwa A.; Koshino T.; Ooka F.; Nishihira M.; Sadatsuki M.; Liang S.G.; Kaibara M.; Mori H.

Effects of estrogen replacement isolated and associated withgestrinone in oophorectomized adult rats with experimental endometriosis
pp. 25-25(1)
Authors: Lobo V.R.; Schur E.; Baracat E.C.; Lang C.E.; Freitas V.; Simoes M.J.; Soares J.M.; Rodrigues de Lima G.

Colour doppler ultrasound analysis of uterine blood vessels in women with endometriosis treated by gonadotrophin releasing hormone agonist zoladex
pp. 26-26(1)
Author: Vasiljevio M.

Clinical and virological features of HIV-associated genital lesions in HIV infected women
pp. 26-26(1)
Authors: Sposetti R.; Franzetti M.; Del Mistro A.; Bonldi E.

E-cadherin and CD44 expression in cervical intraepithelial neoplasia: Comparison between HIV positive and HIV negative women and correlation with HPV status
pp. 26-26(1)
Authors: Darai E.; Walker-Combrouze F.; Benifla J.-L.; Henin D.; Feldmann G.; Madelenat P.; Scoazec J.-Y.

Assisted reproduction of HIV-negative women with ''washed'' sperm of their HIV-positive partners - Risk-reduction or safe procedure?
pp. 26-27(2)
Authors: Melchert F.; Beichert M.; Gentili M.; Weigel M.

HIV infected women: Impact on contraception
pp. 27-27(1)
Authors: Magalhaes J.; Giraldo P.; Amaral E.; Simoes J.A.

Squamous intraepithelial lesions in HIV seropositive pregnant women
pp. 27-27(1)
Authors: Hakim A.; Gueglio R.; Paganini A.; Dunaiewsky A.

Effect of vaginal douching on genital tolerance to nonoxynol-9
pp. 27-27(1)
Authors: Jaisamrarn U.; Thasanapradit P.; Limpongsanurak S.; Taneepanichskul S.

Invasive cervical cancer among women with aids in Europe and USA, 1994-1998
pp. 27-27(1)
Authors: Ebrahim S.H.; Selik R.; McKenna M.; Hamers F.; Seeff L.

Impact of an intervention to improve treatment-seeking behavior and prevent sexually transmitted diseases among nigerian youth: A randomizeed controlled trial
pp. 27-28(2)
Authors: Okonofua F.E.; Coplan P.; Oronsaye F.; Ogunsakin D.; Ogonor J.T.; Collins S.; Kaufman J.A.; Hegenhougen K.

Prevalence of gynaecological risk factors for heterosexual transmission of hiv among women attending centers for counselling and serologic testing in Brazil
pp. 28-28(1)
Authors: Ribeiro-Filho A.D.; Gabiatti J.R.; Giraldo P.C.

HIV-challenges and controversies
pp. 28-28(1)
Authors: Patil A.; Divakar H.

Misoprostol versus oxytocin for labor induction: Randomized controlled trial
pp. 28-28(1)
Authors: Cecatti J.G.; Aquino M.M.A.; Garcia G.M.; Rodrigues T.M.C.

A comparison of oral and vaginal misoprostol tablets in the induction of labor at term
pp. 28-29(2)
Authors: Sherry A.; Danielian P.; Templeton A.

Cervical ripening and induction of labour with misoprostol, prostaglandin E2 or prostaglandin E2 gel: A randomized comparative clinical trial
pp. 29-29(1)
Authors: Nour El-Din N.M.; El-Moghazy D.A.M.

Comparison of oral misoprostol and intramuscular syntometrine in the management of the third stage of labor - A multicenter randomised controlled trial
pp. 29-29(1)
Authors: Na P.S.; Chan A.S.M.; Sin W.K.; Tang L.C.H.; Cheung K.B.; Yuen P.M.

Comparative study on role of syntometrine and prostaglandin in the prevention of P.P.H.
pp. 29-29(1)
Authors: Dutta D.K.; Saha K.K.

Misoprostol and the 3rd stage
pp. 29-29(1)
Author: Chatteriee A.

Randomised controlled trial of intravaginal misoprostol versus intravaginal dinoprostone for the induction of labour
pp. 29-30(2)
Authors: Jackson N.V.; Terzidou V.; Irvine R.E.; Edmonds D.K.; Paterson-Brown S.

Vaginal misoprostol for labor induction 25 ug versus 50ug dose regimens
pp. 30-30(1)
Author: El-Sherbinv M.

Role of estradiol and progesterone receptors in myometrium during labour
pp. 30-30(1)
Authors: Gasparian N.D.; Kareva E.K.; Logutova L.S.; Laricheva I.P.; Levasbova I.I.

Can the risk of ischaemic heart disease be assessed from hysterectomy specimens?
pp. 30-30(1)
Author: Weeks A.

Transdermal hormone replacement therapy for secondary prevention of coronary artery disease in postmenopausal women
pp. 30-30(1)
Authors: Clarke S.; Slack M.; Kelleher J.; Schofield P.

Long-term treatment with the progestogens medroxyprogesterone acetate (MPA) and norethisterone acetate (NETA) displays different vascular effect
pp. 31-31(1)
Authors: Pedersen S.; Pedersen N.G.; Dalsgaard T.; Nilas L.; Ottesen B.

Endothelin-1 induced vasoconstriction variates with the progestogen used for pretreatment
pp. 31-31(1)
Authors: Pedersen N.G.; Pedersen S.; Dalsgaard T.; Nilas L.; Ottesen B.

Fat distribuition and risk factors for cardiovascular disease in post menopausal women
pp. 31-31(1)
Authors: Filip Raskin D.; Pinto Neto A.; Neves Jorge J.; Costa Paiva L.

Hormone replacement therapy decreases norepinephrine plasma levels in postmenopausal women
pp. 31-31(1)
Authors: Molina C.; Arata de Bellabarba G.; Velazquez E.; Villarroel V.

The effects of twelve month use of an estradiol/norgestrel preparation by postmenopausal women on lipid metabolism and hemostatic parameters
pp. 32-32(1)
Authors: El-Nashar I.H.; Sayed G.H.; El-Kabsh M.; Nasr A.; Shaaban M.N.

Comparison of the effects of estrogen vs estrogen plus progesteron regimens on CRP and homocysteine levels
pp. 32-32(1)
Authors: Yarali H.; Yildirir A.; Aybar F.; Tokogozoglu L.; yarah H.; Kabaker G.; Bukulmez O.; Sinici I.; Unsal I.; Oto A.; Gurgan T.

Diagnosis and endoscopic management of fallopian tube torsion: Prior history of tubal sterilization and pelvic inflammatory disease (PID) as independent risk factors
pp. 32-32(1)
Authors: Sozen I.; Arici A.

Hyperosmolar glucose instillation versus salpingostomy by laparoscopy in unruptured tubal pregnancy with serum szHCG levels < 2500 UI/L
pp. 32-33(2)
Authors: Arikan M.G.; Scholz H.S.; Jelinek B.; Basver A.; Tamussino K.; Giuliani A.; Haas J.; Lang P.

Laparoscopic tubal end-to-end anastomosis after sterilization
pp. 33-33(1)
Authors: Mettler L.; Lehman-Willenbrock E.

Laparoscopic electrocauterization of polycystic ovaries: Prediction of the outcome
pp. 33-33(1)
Authors: Kamel H.; Zakhira M.; Mostafa S.; Selim S.; Abullah S.

Laparoscopic ovarian drilling of polycystic ovarian disease (PLOD): Comparison between endocoagulation and electrocauterization
pp. 33-33(1)
Authors: Abdullah S.A.; Mostafa S.A.; Selim S.M.; Zakhera M.S.

Laparoscopic ovarian electrocautery for management of polycystic ovarian disease
pp. 33-33(1)
Authors: Kriplani A.; Agarwal N.; Takkar D.

Chromopertubation with flexible cannula in laparoscopic examination and reconstructive surgery treatment for distal tubal disease
pp. 33-34(2)
Authors: Efimenco A.; Ivasi M.; Nacu L.; Bejan F.

Charmonic scalpel in laparoscopic cystectomy in infertility
pp. 34-34(1)
Authors: Garaleiic E.; Antic N.; Arsic B.; Vasiljevic M.; Maglic R.; Vasic B.

Manual vaccum aspiration: Reducing unsafe abortion and maternal mortality
pp. 34-34(1)
Authors: Adesse L.; Trottier D.; Martins J.F.

Maternal mortality in India and strategies for reduction
pp. 34-34(1)
Authors: Swain S.; Agrawal A.; Raghavan S.S.; Oumachigui A.; Rajaram P.

Maternal mortality in eclampsia
pp. 34-34(1)
Author: Nobis P.

Direct maternal deaths and health care facility
pp. 34-35(2)
Authors: Bagga R.; Gopalan S.; Malhotra D.; Jain V.

An analysis of the maternal mortality at a tertiary level referral center
pp. 35-35(1)
Authors: Tilwani K.P.; Kulkarni N.P.

Maternal mortality & morbidity in acute renal failure
pp. 35-35(1)
Authors: Chavan N.; Chavan K.N.; Shirodkar S.D.; Badhwar V.R.

Causes of maternal mortality(1975-1999): Results from the largest maternity hospital of Turkey
pp. 35-35(1)
Authors: Yapar Eyi E.G.; Gulerman C.; Gokmen O.

Perinatal substance abuse treatment decreases need for neonatal assisted ventilation
pp. 35-35(1)
Authors: Armstrong M.A.; Carpenter D.M.; Lieberman L.; Midanik L.T.; Gonzales V.M.; Escobar G.J.

Cerebral palsy and cord around the neck at birth-A spurious association?
pp. 36-36(1)
Authors: Greenwood C.E.L.; Impey L.W.; Sellers S.; McDonald E.M.; Johnson A.

Aetiology and outcome of fetal hydrops: Retrospective case series
pp. 36-36(1)
Authors: Ismail K.M.K.; Martin W.L.; Ghosh S.; Whittle M.J.; Kilby M.D.

Inhaled nitric oxide improved survival in high-risk congenital diaphragmatic hernia
pp. 36-36(1)
Authors: Stranak Z.; Janota J.; Pycha K.; Snajdauf J.; Rygl M.; Feyereisl J.

Low apgar scores - Causes and significance
pp. 36-36(1)
Authors: Jain V.; Bagga R.; Gopalan S.; Narang A.

Peculiarities of immune system of neonates of mothers with antiphospholipid syndrome
pp. 37-37(1)
Authors: Ponomarova L.P.; Vanko L.V.; Bondar O.E.; Matveeva N.K.; Loginova N.S.

Maternal and umbilical cord blood lead levels in Tehran, Iran
pp. 37-37(1)
Authors: Akbarian A.; Mehdizadeh A.; Khalilipour M.; Moshfegi M.; Mogtahedi M.; Alaghehbandan R.

The effect of mode of delivery on neonatal outcome of twins with birthweight under 1500g
pp. 37-37(1)
Authors: Ziadeh S.M.; Sunna E.; Badria L.F.

Ovarian cancer detected non-invasively by contrast enhanced power doppler ultrasound
pp. 37-37(1)
Authors: D'Arcv T.; Lynch M.; Soutter P.; Cosgrove D.

Using logistic regression model to predict ovarian malignancy: Which parameter performs best?
pp. 38-38(1)
Authors: Marret H.; Ecochard R.; Golfier F.; Raudrant D.

Clinical evaluation of computer aided multivariate pattern analysis system II (campas OV II) for discriminating malignant from benign ovarian masses (BOM)
pp. 38-38(1)
Authors: Kimura E.; Kobayashi S.; Oura K.; Yasuda M.; Ochiai K.; Tanaka T.

A new histopathologic grading system for ovarian carcinoma
pp. 38-38(1)
Authors: Shimizu Y.; Hasumi K.; Kamoi S.; Amada S.; Silverberg S.G.

Fine needle aspiration cytology in diagnosis of pelvic adnexal masses
pp. 38-38(1)
Authors: Goval S.; Kalra J.; Gopalan S.

Using a logistic regression model to predict ovarian malignancy based on gray-scale and color doppler ultrasound findings combined with angiogenic cytokines serum levels
pp. 39-39(1)
Authors: Czekierdowski A.; Zrubek H.; otarski J.

The ability of dynamic contrast enhanced MRI (DCE-MRI) to predict malignancy of ovarian carcinoma
pp. 39-39(1)
Authors: Hall G.H.; Atkin S.L.; Turnbull L.W.

Comparison of accuracy of diagnostic ovaries cyst between vaginal sonography and cytology finding
pp. 39-39(1)
Authors: Aflatounian A.; Aflatounian R.

The interventional ultrasound in diagnostics and treatment of ovarian masses
pp. 39-39(1)
Authors: Artyomenko V.; Zelynsky A.; Lebedenko V.

Comparison of standard and low dose long acting gonadotropin releasing hormone agonist (triptorelin) administration prior to ovarian stimulation for in vitro fertilization
pp. 40-40(1)
Authors: Haines C.J.; Yim S.F.; Cheung L.P.; Briton-Jones C.M.; Chin T.T.Y.

Co-appearance of progesterone receptor (PR) down-regulation and pinopodium formation as implantation window markers in REC-FSH / GnRH analogue induced cycles
pp. 40-40(1)
Authors: Ugocsai G.; Berecz E.; Paszty E.; Rozsa M.

Randomized comparative study of recombinant versus highly purified urinary follicle stimulating hormone in controlled ovarian stimulation: Our experience
pp. 40-40(1)
Authors: Chakravarty B.N.; Chattopadhyay R.; Ghosh S.; Goswami S.K.; Kabir S.N.

Two-phase hormonal preparation in poor responders: How it affects the cancellation rate in IVF & ICSI cycles
pp. 40-41(2)
Authors: El Deeb W.; Farid S.; Darwish E.; El-Sahwi S.

A prospective randomised study to ascertain if gonadotrophins with differing FSH:LH ratios affect oocyte maturation, fertilisation and outcome in assisted conception cycles
pp. 41-41(1)
Authors: Irvine R.E.; Abdalla H.I.; Studd J.W.

Cabergoline for poor responders. A new approach
pp. 41-41(1)
Author: Shawkv H.

Oocyte retrieval rate through repeated controlled ovarian hyperstimulation cycles in donors
pp. 41-41(1)
Authors: Califara C.; Vargas G.; Cuneo S.; Rodrguez M.; Simon C.; Pellicer A.; Remohi J.

Ovarian response during use of hormone agonist protocols
pp. 42-42(1)
Authors: Isjanovska E.S.; Adamoska-Klisaroska S.; Isjanovski S.

Recurrent miscarriage - an aspirin a day?
pp. 42-42(1)
Authors: Rai R.; Backos M.; Reagan L.

Pre pregnancy thrombophilic abnormalities are associated with subsequent miscarriage
pp. 42-42(1)
Authors: Regan L.; Rai R.; Tuddenham E.; Backos M.

Recurrent miscarriage
pp. 42-43(2)
Authors: Formosa M.; Brincat M.

Predictive value of 3 dimensional volumetry of gestational and yolk SAC for pregnancy outcome in tie first trimester
pp. 43-43(1)
Authors: Babinszki A.; Nyari T.; Mukheriee T.; Copperman A.B.

The pattern of recurrent pregnancy loss in Kuwait
pp. 43-43(1)
Authors: Diejomaoh F.M.E.; Al-Azemi M.; Jirous J.; Bandar A.; Egbase P.; Al-Sweih N.; Al-Othman S.

Epidemiology of spontaneous recurrent abortion
pp. 43-43(1)
Author: El-Zibdeh M.Y.

Low levels of endometrial decay accelerating factor (CD55) may be an indicator of spontaneous abortion
pp. 43-44(2)
Authors: Martens M.; Kaul A.; Brown D.; Kaul R.

Threatened abortion outcome in relation to intrauterine clot site and not only volume
pp. 44-44(1)
Authors: Patel B.I.; Trivedi V.

G-CSF concentrations of mothers' serums as the marker of the prognoses of patients with gs but without FHB
pp. 44-44(1)
Authors: Tomizawa H.; Goo Y.-L.; Ohshima K.; Fujii R.; Iura T.; Makinoda S.

Karyotype of the abortus in recurrent miscarriage
pp. 44-44(1)
Authors: Carp H.J.A.; Toder V.; Orgad S.; Aviram A.; Mashiach S.; Barkai G.

Do mast cells propagate sub-endometrial contractions?
pp. 44-44(1)
Author: Tetlow R.

Kinetics of IGFBP-1 in cervix during medical termination of early human pregnancy
pp. 45-45(1)
Authors: Honkanen H.; Rutanen E.-M.; Heikinheimo O.

Congenital malformation occurring as a result of pre-implantation exposure of mouse embryos to ammonium chloride
pp. 45-45(1)
Author: Sinawat S.

Ultrastructural imaging of human in vitro fertilization and early embryogenesis
pp. 45-45(1)
Authors: Makabe S.; Naguro T.; Motta P.M.

Assisted reproduction in histopathologically proven endometrial kochs
pp. 45-45(1)
Authors: Desai S.; Roy P.G.; Hansotia M.D.

Morphologic endometrial studies of adult rats submitted to continuous light and after melatonin administration
pp. 46-46(1)
Authors: Haidar M.A.; Hinoue E.I.; Lang C.E.; Soares J.M.; Simoes M.J.; Rodrigues de Lima G.; Baracat E.C.

Influence of alloimmunization on the cellular and humoral immune response in women with RSA of unknown cause
pp. 46-46(1)
Author: Stukalova O.

Periurethral autologous fat injection as a treatment for female stress urinary incontinence
pp. 46-46(1)
Authors: Lee P.; Kung R.; Drutz H.

Urethro-raphy - a new technique for surgical management of stress urinary incontinence (SUI)
pp. 46-46(1)
Authors: El Hemalv M.A.A.; Kandil I.M.; Radwan M.M.

Efficacy of laparoscopic bladder autoaugmentation for women with detrussor instability and low bladder compliance
pp. 46-47(2)
Authors: Afifv A.W.M.; Rasheed M.

Convalescence recommendations following vaginal surgery for utero-vaginal prolapse
pp. 47-47(1)
Authors: Ottesen M.; Moeller C.; Kehlet H.; Ottesen B.

The combination of kovac-procedure with pelvic floor repair is an improved method for correcting stress urinary incontinence
pp. 47-47(1)
Authors: Retzke U.; Hagemeier H.-J.; Skrobol M.; Illing R.; Graf H.

A new adjustable balloon (ACT) for female incontinence
pp. 47-47(1)
Authors: Pacetta A.M.; Sadi M.V.; Carramao S.C.; Almeida F.M.R.

About 2244 urinary stress incontinence operations
pp. 48-48(1)
Authors: Lazarevski M.; Iliev V.; Badzakov N.; Antovska V.

Study of the results of surgical treatment of incontinence on patients with prolapse of the genitals
pp. 48-48(1)
Authors: Buyanova S.N.; Petrova V.; Ioseliani M.N.; Rizhinashvili I.D.; Balashov V.I.

Laparoscopy for surgical treatment of genital descent and urinary incontinence
pp. 48-48(1)
Authors: Kulakov V.; Adamyan L.; Sashin B.; Blinova M.

Use of a new vessel ligation device during vaginal hysterectomy
pp. 48-48(1)
Author: Levy B.

587 cases of vaginal adnexectomy
pp. 48-49(2)
Author: Larson S.L.

Attitude change is all that is required to reverse the ratio of abdominal to vaginal hysterectomies. A prospective study
pp. 49-49(1)
Authors: Varma R.; Tahseen S.

Audit of assesment of feasibility of vaginal hysterectomy
pp. 49-49(1)
Authors: Deshpande N.; Olah K.S.J.

Vaginal hysterectomy: Safe without posthysterectomy vault prolapse
pp. 49-49(1)
Author: Lotfi G.

Transvaginal ovarian cystectomy
pp. 49-49(1)
Authors: Choi H.S.; Kim S.M.; Byun J.S.

Vaginal hysterectomy for the undescended uterus - analysis of factors predicting feasibility
pp. 50-50(1)
Author: Sinha R.

Vaginal hysterectomy on non-prolapsed UTERI: Our clinical experience
pp. 50-50(1)
Authors: Bratila P.; Nicodin O.; Niculescu N.

Widespread indication of vaginal hysterectomy with Schurchardt's incision
pp. 50-50(1)
Authors: Matthes A.; Marana H.; Matthes A.G.

Pregnancies and live uninfected children born from couples with an HIV-1 seropositive man after intracytoplasmic sperm injection
pp. 50-50(1)
Authors: Loutradis D.; Bletsa R.; Michalas L.; Kallianidis K.; Drakakis P.; Patsoula E.; Michalas S.

First Hungarian pregnancies-deliveries after ICSI using originally unmoving spermatids obtained from cryopreserved testicular tissue
pp. 51-51(1)
Authors: Kanyo K.; Konc J.

The significance of endometrial thickness on implantation and number of embryo transferred on pregnancy outcome in an intracytoplasmic sperm injection program
pp. 51-51(1)
Authors: Tantoco C.; Almeda L.; Vera T.

Assisted oocyte activation by electrical stimulation after intracytoplasmic sperm injection
pp. 51-51(1)
Authors: Lee M.-S.; Huang C.-C.; Chen C.-I.

A prospective study comparing testicular and ejaculated spermatids for predicting the probability of testicular sperm extraction in men with non-obstructive azoospermia
pp. 51-51(1)
Authors: Ezeh U.I.O.; Moore H.D.M.; Cooke I.D.

Does tubal sperm perfusion improve the results of intrauterine insemination?
pp. 52-52(1)
Authors: El-Adawv A.; Ibrahim M.; Abd El-Hady F.

ICSI experience in pakistan: Male infertility, azoospermia, ICSI
pp. 52-52(1)
Authors: Khan Y.; Siddiq S.; Khan M.

Surgical sperm retrieval in cases of azoospermia: Male infertility, TESA, PESA, TESE, azoospermia
pp. 52-52(1)
Authors: Siddiu S.; Khan M.; Siddiqi K.

Tamoxifen treatment of benign mammary dysplasia: A 6-year follow up
pp. 52-52(1)
Author: Gargiulo F.

Evolution of invasive breast cancer between 1989-1998 In the hospital of barbastro (Spain)
pp. 52-53(2)
Authors: Oncins R.; Fuente C.; Bitrian A.; Alonso M.; Mature M.; Carrasquer J.A.; Florian J.

Early detection of breast cancer by analysis of P43 positive lymphocytes from peripheral blood
pp. 53-53(1)
Authors: Auerbach L.; Hellan M.; Stierer M.; Rosen A.C.; Obwegeser R.; Kubista E.; Wolf G.; Moroz C.; Rosen H.R.; Panzer S.

The association between breast cancer and thyroid disease
pp. 53-53(1)
Authors: Tjalma W.; Cooremans I.; Bu P.

Frequent expression of c-erbB-2 and p53 in itraductal comedocarcinoma of the breast
pp. 53-53(1)
Authors: Xu W.; To X.; Zhang T.; Shi D.; Ji H.

Correlation between plasma tamoxifen concentration and tumor response in patients with breast cancer
pp. 53-53(1)
Authors: Matthes A.; Bighetti S.; Lanchote V.; Carrara H.

A study of apoptosis in normal breast tissue in tamoxifen-treated premenopausal women with fibroadenoma
pp. 54-54(1)
Authors: Gebrim L.H.; Seixas M.T.; Baracat E.C.; Lima G.R.

Tumor cells in bone marrow of breast cancer patients with locoregional recurrence or distant metastases
pp. 54-54(1)
Authors: Janni W.; Gastroph S.; Hepp F.; Kentenich C.; Rjosk D.; Schindlbeck C.; Sommer H.; Braun S.

Prognostic impact and therapeutical options for breast cancer patients with micrometastatic disease
pp. 54-54(1)
Authors: Diel I.J.; Solomayer E.F.; Gollan C.; Schatz F.; Bastert G.

Anti-HER-2/NEU antibody induces apoptosis in HER-2/NEU overexpressing breast cancer cells independent from intact P53
pp. 54-54(1)
Authors: Brodowicz T.; Tomek S.; Kandioler-eckersberger D.; Rudas M.; Kosler W.J.; Ludwig C.; Budinsky A.; Hejna M.; Krainer M.; Wiltschke C.; Zielinski C.C.

Management of rectovaginal fistula at Dr. Cipto Mangunkusumo general hospital
pp. 55-55(1)
Authors: Suskhan D.; Santoso B.; Yunizaf Z.

Evaluation of laparoscopy: How efficiently can a developing country cope?
pp. 55-55(1)
Authors: Abdel-Rahim H.E.F.; Younis M.N.; El-Hemaly A.M.A.; Flamed A.F.

Obstetric trauma in kenya (a continuing challenge)
pp. 55-55(1)
Author: Omamo-Nyamogo M.A.

Extra and intra peritoneal abdominal repair of V.V. fistulae
pp. 55-55(1)
Author: Abbo A.H.

Long term results of rectovaginal fistula repair: Retrospective analysis of 48 cases
pp. 55-56(2)
Authors: Darai E.; Soriano D.; Lemoine A.; Laplace C.; Deval B.; Dessolle L.; Poitout P.

The damaging effects of estrogen-active substances on women - analysis of concentration levels in urine through use of gas chromatography - mass spectrometry (GC-MS)
pp. 56-56(1)
Authors: Frigo P.; Worda C.; Huber J.C.

The hysterectomy after cesarean section - the analysis of indications, post-operative period course and pathopmorphological outcome
pp. 56-56(1)
Authors: Gajeuska M.; Marianowski L.

Domiciliary care for oncological patients without therapeutic chance
pp. 56-56(1)
Authors: Mottola J.J.R.; Diniz L.; Santos A.C.; Garcia N.; Felipe C.; Laginha F.M.; Alercin I.N.; Marques J.A.

Hurdles of gynecological oncology in Southern Africa
pp. 56-56(1)
Authors: Maseela T.; Moja L.V.M.

Quality of patient information on female sterilization and menorrhagia on the internet
pp. 57-57(1)
Authors: Latthe P.; Latthe M.; Khan K.

Neural network analysis or preoperative variables and outcome in anal sphincter repair
pp. 57-57(1)
Authors: Gardiner A.; Baxter A.; Kaur G.; Phillips K.; Duthie G.S.

Influence of fetal heart rate decelerations, in the computerized study of fetal heart rate variability during labor
pp. 57-57(1)
Authors: Briozzol L.; Alonsol J.; Martinez A.; Migliaro A.; Migliaro E.R.

Do fetuses ''at risk'' benefit from hospital stay?
pp. 57-57(1)
Authors: Petrikovskv B.; Schneider E.; Rochelson B.

Antiphospholipid antibodies in preeclampsia
pp. 57-58(2)
Authors: Mourashko L.E.; Gorodnitcheva J.A.; Khodova S.I.; Sukhikh G.T.

Difficulties in adaptation for pregnancy in women after 35 years old
pp. 58-58(1)
Authors: Uczak-Waaryzniak J.; Szczepa_ska M.; Skrzypczak J.

The internet, the world wide web and beyond in the obstetric & gynaecological practice today
pp. 58-58(1)
Authors: Hai Mohideen M.; Kessler L.

New technology for the obstetrician in the new millennium
pp. 58-58(1)
Authors: Haj Mohideen M.; Abdul Salam S.; Kessler L.

Improving training for obstetrics and gynecology residents in abortion and family planning in the United States
pp. 58-59(2)
Authors: Landv U.; Darney P.

Attitudes on family planning in medical school students
pp. 59-59(1)
Author: Pierdant G.

Lessons learned from two years of in-service-training for midwives at onandjokwe hospital in Northern Namibia
pp. 59-59(1)
Authors: Meguid T.; Ikeakanam O.; Petrova V.A.

Patient management problems (PMPS) as a learning tool for continuing medical education for physicians at primary care setting in Bangladesh
pp. 59-59(1)
Author: Tasnim S.

Life saving skills training in Malawi: Is it any use?
pp. 59-59(1)
Authors: Makawa J.A.; Jonazi M.; Hussein J.; Bokosi M.

Training model based on competency in medical education in Turkey: Lessons learned form family planning traning experience
pp. 60-60(1)
Authors: Ozek B.; Tuzer T.; Bahar S.; Sahin N.

Evaluation of strengthening family planning training conducted in eight midwifery vocational high and two university based midwifery schools
pp. 60-60(1)
Authors: Ozek B.; Tozer T.; Saar Z.; Aybas G.; Demir G.; Temiz A.

A structured training program for family planning and reproductive health care
pp. 60-60(1)
Authors: Newton J.; Walton S.

Trends and perspectives of the written part I examination of the obstetrics and gynecology accreditation examination in a developing country
pp. 60-60(1)
Author: De Jesus V.

Signaling pathways involved in epidermal growth factor (EGF) induced proliferation of ovarian cancer cell lines
pp. 61-61(1)
Authors: Sundborg M.J.; Manzanol R.G.; Carlson J.W.; Birrerl M.J.

BCL-2 expression in normal, hyperplastic and malignant endometrium
pp. 61-61(1)
Authors: Monayeri M.S.; Eldeep T.; Bayoumi N.; Hassan M.; Wahab M.; Eldeeb T.; Aly H.

Absence of p51 alteration in human ovarian carcinoma
pp. 61-61(1)
Authors: Shinozaki H.; Okamoto A.; Tanaka T.; Ochiai K.; Shimizu K.; Saito M.; Takakura S.; Yokota J.

Low specificity of cytokeratin 19 mRNA expression in the peripheral blood cells from patients with ovarian tumors
pp. 61-61(1)
Authors: Okamoto A.; Takano H.; Tanaka T.; Ochiai K.; Saito M.; Isonishi S.

Expression of matrix metalloproteinases and related tissue inhibitors in ovarian neoplasms
pp. 62-62(1)
Authors: Furuya M.; Ishikura H.; Yoshiki T.

Taxoxifen modulates the apoptotic pathway of primary endometrial cell culture
pp. 62-62(1)
Authors: Drucker L.; Stackievicz R.; Yarkoni S.; Radnay J.; Beyth Y.; Cohen I.

Immunohistochemical research of thymidine phosphorylase in human endometrial cancer
pp. 62-62(1)
Authors: Guo Y.; Wei L.; Fu Q.; Yu Y.

Impaired production of tumour necrosis factor-, defective expression of ICAM-1 in healthy women with germline mutations of BRCA1
pp. 62-62(1)
Authors: Wiltschke C.; Budinsky A.C.; Wagner T.m.u.; Wolfram R.M.; Kostler W.J.; Kubista M.; Brodowicz T.; Kubista E.; Zielinski C.C.

Hormone replacement therapy after endometrial cancer treatment: preliminary results
pp. 62-63(2)
Authors: Moroy P.; Gokmen O.; Ozdener T.; Aktulay A.; Turkcapar F.; Gulerman C.

The specific activity of delta-8,9-dehydroestrone on bone resorption and other physiological properties associated with menopause
pp. 63-63(1)
Authors: Pickar J.; Baracat E.; Haider M.; Lopez F.J.; Dey M.; Negro-Vilar A.

Osteoporosis screening on high dose steroid using postmenopausal females: a letter outreach study
pp. 63-63(1)
Author: Binstock M.

The impact of estrogen deficiency and therapy on women's oral health
pp. 63-63(1)
Author: Steinberg B.J.

Hormone replacement therapy on special conditions: rheumatoid arthritis
pp. 63-63(1)
Authors: Rosas F.C.; Fonseca A.M.; Bagnoli V.R.; Cardim H.J.P.; Poveda E.; Assis J.S.; Pinotti J.A.

Clinical and laboratorial evaluation in elderly women submitted to low doses of hormone replacement therapy (HRT)
pp. 64-64(1)
Authors: Fonseca A.M.; Massabki J.O.P.; Arie M.H.A.; Margarido P.F.R.; Hayashida S.A.Y.; Bagnoli V.R.; Pinotti J.A.

Bone density and skin thickness changes in postmenopausal women on long term corticosteroid therapy
pp. 64-64(1)
Authors: Muscat Baron Y.; Galea R.; Brincat M.

Sexual behavior among adolescents in Sweden -a ten-year follow-up study
pp. 64-64(1)
Authors: Haggstrom-Nordin E.; Hanson U.; Tyden T.

Sexual symptoms at menopause and their relationship with other climacteric complaints
pp. 64-65(2)
Authors: Nappi R.E.; Polatti F.; Baldaro Verde J.; Genazzani A.R.

History of sexual abuse and gynecological examination in Danish patients visiting gynecological in-and out-patient clinic
pp. 65-65(1)
Author: Hilden M.

A study of Japanese dyspareunia in patients with endometriosis
pp. 65-65(1)
Authors: Seki M.K.; Hamazaki K.; Kashimura M.

Sexual behavior in climateric women
pp. 65-65(1)
Authors: Penteado S.R.L.; Fonseca A.M.; Cavalcanti A.M.; Parellada C.I.; Bagnoli V.R.; Pasqualotto E.B.; Halbe H.W.

A pilot study of the effect of viagra(R) on vaginal blood flow (VBF) in female subjects
pp. 65-65(1)
Authors: Laan E.; van Lunsen R.H.W.; Riley A.; Scott L.; Boolell M.

Evaluation of the effects of phentolamine mesylate on vaginal blood flow response in postmenopausal women with female sexual dysfunction
pp. 65-66(2)
Authors: Rubio E.A.; Lopez M.; Lipezeker M.; Rampazzo C.

Microwave endometrial ablation in women with a fibroid uterus
pp. 66-66(1)
Authors: Ellard M.A.; Hayes T.; Sharp N.C.

Endometrial hydrothermal ablation: a new, simple treatment for menorrhagia
pp. 66-66(1)
Authors: Hefni M.; El-Toukhy T.; Davies A.E.; Morris E.

Premalignant/malignant outcome in abnormal uterine bleeding evaluated by hysteroscopy, ultrasonography & tissue sampling: a cohort study
pp. 66-67(2)
Author: Bakour S.H.

Endometrial ablation and uterine artery blood flow: results of a prospective longitudinal study
pp. 67-67(1)
Authors: Okolo S.; Mohammed K.

Operative hysteroscopy, an analysis of 286 cases
pp. 67-67(1)
Authors: Prevedourakis C.; Makris N.; Dachlythas M.

Endometrial laser intrauterine thermal therapy (ELITT): A new approach to the treatment of menorrhagia
pp. 67-67(1)
Authors: Donnez J.; Nisolle M.; Polet R.

Thermal endometrial ablation with foley catheter balloon
pp. 67-67(1)
Authors: Singh K.C.; Sengupta R.; Agarwal N.; Misra K.

Tools and techniques to facilitate office based endometrial sampling
pp. 67-68(2)
Author: Jackson R.

Dilation of cervix in outpatient hysteroscopy: a randomized double-blinded controlled study of local lignocaine effect on pain scoring
pp. 68-68(1)
Authors: Wong A.Y.K.; Wong K.S.; Tang L.C.H.

An objective measure of cervical ripeness at induction of labour using electrical impedance measurements
pp. 68-68(1)
Authors: O'Connell M.P.; Wisher S.; Avis N.J.; Brown B.H.; Killick S.R.; Lindow S.W.

Group B streptococcus acquisition and infection rate after under water delivery
pp. 68-68(1)
Authors: Zanetti Dallenbach R.A.; Hosli I.; Frei R.; Holzgrevel W.

Phase II to determine the potential efficacy and safety of nitric oxide for cervical ripening in pregnancy at term
pp. 68-69(2)
Authors: Chanrachakul B.; Herbutya Y.

Preinduction cervical ripening: A comparison of extraamniotic foley catheter balloon and intracervical prostaglandin E₂ gel
pp. 69-69(1)
Authors: Suri V.; Dalui R.; Gupta I.; Ray P.

A randomised controlled trial of extra amniotic saline infusion and intracervical foley catheter for cervical ripening
pp. 69-69(1)
Authors: Jasper M.P.; Blossom S.; Peedicayil A.

Induction of labor with intracervical prostglandin E2 in women with one previous cesarean section
pp. 69-69(1)
Authors: George S.M.; Rai A.; Gadiyar P.

Meconium stained amniotic fluid full term singleton vertex presentation-appropriate birthing care
pp. 69-69(1)
Authors: Sundravalli A.; Joshna S.; Shanmuga G.; Shanti A.

Determinants of perinatal mortality among breech delivery in a developing country
pp. 69-70(2)
Author: Olatinwo A.W.O.

Maternal and perinatal outcome in pregnancies with rheumatic heart disease
pp. 70-70(1)
Authors: Vasishta K.; Sawhney H.; Aggarwal N.; Suri V.; Grover A.; Dhaliwal R.

Indian scenario in pregnancy with heart disease
pp. 70-70(1)
Authors: Chinnakannu V.; Srinivas D.

Maternal and perinatal outcome in 300 pregnant women with heart disease. ICU management
pp. 70-70(1)
Authors: Sundaravalli A.; Gajalakshmi S.; Famidha D.; Manimekalai S.

Study of the pregnancy in adolescents with heart disease in a specialized service of heart disease and pregnancy
pp. 70-70(1)
Authors: Watanabe C.; Andrade J.; Sousa J.

Thromboprophylaxis with low-molecular-weight heparin in women with cardiac pathology during pregnancy
pp. 71-71(1)
Authors: Bitsadze V.O.; Ismailova S.G.; Khamami I.V.; Makatsaria A.D.

Course and fetal outcome of pregnancies in patients with the surgical correction of congenital or acquired health disease
pp. 71-71(1)
Authors: Plesinac S.; Plecas D.

Vaginal ulceration (Bechet's disease) in pregnancy: a case report
pp. 71-71(1)
Authors: Kesic V.; Bozanovic T.; Vukmirovic L.J.; Opalic J.; Atanackovic J.

Trimetazidine in the treatment of chronic fetal hypoxia in pregnant women with congenital heart diseases
pp. 71-72(2)
Authors: Medved V.; Islamova E.; Solonets N.; Podolsky V.

Psychosocial and obstetric risk factors for postpartum depression
pp. 72-72(1)
Authors: El-Kak F.; Chaaya M.

Primary appendiceal malignancy mimicking advanced stage ovarian carcinoma: a case series
pp. 72-72(1)
Authors: McBroom J.; Parker M.; Krivak T.; Rose G.S.

A dose finding study of docetaxel/carboplatin as first-line. Chemotherapy for epithelial ovarian cancer - final results
pp. 72-72(1)
Authors: Atkinson R.; Vasey P.A.; Coleman R.; Crawford M.; Cruickshank M.; Eggleton P.; Fleming D.; Graham J.; Parkin D.; Paul J.; Reed N.S.; Kaye S.B.

Cisplatin, epirubicin and paclitaxel combination chemotherapy in previously untreated patients with advanced epithelial ovarian cancer
pp. 72-72(1)
Authors: Papadimitriou C.; Lazaris D.; Rodolakis A.; Kiamouris C.; Gourgoulis G.M.; Galani E.; Diakomanolis E.; Michalas S.; Dimopoulos M.A.

Current status of gene therapy for ovarian cancer
pp. 73-73(1)
Author: Farghaly S.A.

Expression of drug resistance-associated markers P-GP, MRP1, MRP2 and LRP in ovarian cancer: clinical implications
pp. 73-73(1)
Authors: Katsaros D.; Arts H.J.G.; Massobrio M.; Van der Zee A.J.H.

A paclitaxel-containing chemotherapy in patients with ovarian cancer does not cause encephalopathy: a prospective resting-EEG (R-EEG) mapping study in 28 patients
pp. 73-73(1)
Authors: Mayerhofer K.; Bodner K.; Saletu B.; Bodner-Adler B.; Anderer P.; Schindl M.; Kaider A.; Hefler L.; Leodolter S.; Kainz C.

Whole-body FDG pet for the detection of recurrent sites in advanced gynecological malignancies
pp. 73-74(2)
Authors: Murakami M.; Maeda H.; Hirasawa T.; Muramatsu T.; Miyamoto T.; Shinozuka T.; Makino T.; Yasuda S.; Suzuki Y.; Ide M.; Shohtsu A.

A ten year analysis of 600 cases of ovarian cancer
pp. 74-74(1)
Authors: Banerjee S.K.; Gupta K.; Mondol N.R.

Gemcitabine (G) + carboplatin (C) as 2^nd line therapy in gynaecologic cancer patients: a phase I/II study of the arbeitsgemeinschaft Gynakologische Onkologie (AGO) study group
pp. 74-74(1)
Authors: Quaas J.; Luck H.J.; Schroder W.; Blohmer J.; Kimmig R.; Mobus V.; Pfisterer J.

Resistance to activated protein C during pregnancy: low molecular weight heparin for obsteric thrombo prophylaxis
pp. 74-74(1)
Authors: Barjot P.; Beucher G.; Linder Y.; Herlicoviez M.

The prevalence of the factor V leiden mutation in preeclampsia and superimposed preeclampsia: implications for clinical outcomes
pp. 74-74(1)
Authors: Rigo J.; Nagy B.; Ban Z.; Papp Z.

Factor V Leiden as a risk factor for miscarriage and reduced fertility
pp. 75-75(1)
Authors: Poka R.; Bare S.; Balogh I.

Factor V Leiden may be responsible for worsening perinatal fetal outcome in women with venous thrombosis at young age
pp. 75-75(1)
Authors: Pajor A.; Nemes L.; Fontanyi Z.; Szen L.; Sebok T.; Fodor G.M.; Cegledi A.; Paulin F.

Effect of antiphospholipid antibody types on pregnancy outcome
pp. 75-75(1)
Authors: Backos M.; Rai R.; Tower C.; Regan L.

Antiphospholipid antibodies (APA) and pregnancy outcome
pp. 75-75(1)
Authors: Fernandez E.; Surapaneni T.

Effects of folic acid supplementation during pregnancy and the risk of severe preeclampsia
pp. 75-76(2)
Authors: Canete M.L.; Sanchez-Dehesa A.; Lafuente P.; Rodriguez O.; Sanchez J.M.; Munoz E.; Sanchez-Dehesa M.

Pregnancy, labor and postpartum period in patients with factor V Leiden mutation
pp. 76-76(1)
Authors: Starchenko K.V.; Bitsadze V.O.; Sincha A.; Makatsaria A.D.

Prevention of repeated thrombosis in pregnant with hereditary and acquired thrombophilia
pp. 76-76(1)
Authors: Makatsaria A.D.; Bitsadze V.O.; Genievskaya M.G.; Starchenko K.V.; Matveeva T.

The frequency and nature of birth defects undetected by midpregnancy ultrasound screening
pp. 76-76(1)
Author: Ogburn P.

Renal artery hemodynamic response to invasive procedures and the effect of analgesia
pp. 76-76(1)
Authors: Teixeira J.M.A.; Glover V.

A five year review of amniocentesis procedures
pp. 77-77(1)
Author: Urquhart D.R.

Interactive multimedia CD rom to teach fetal anomaly recognition
pp. 77-77(1)
Authors: Loquet P.; Deutchman M.

Extensive prenatal diagnosis: antenatal gene tests for pregnant women eligible for chorion villus biopsy or amniocentesis
pp. 77-77(1)
Authors: Kallinen J.; Heinonen S.; Palotie A.; Ryynanen M.

Prenatal detection of singe umbilical artery and hypoplastic artery: Review of 51 cases
pp. 77-78(2)
Authors: Gagaev C.G.; Kostin I.N.; Semyatov S.M.

Transabdominal fetoscopy; Possible role for early detection of fetal anomalies
pp. 78-78(1)
Authors: Rakic S.; Mikovic Z.; Antic N.; Filimonovic D.

The effect of pre and postovulatory treatment with levonorgestrel and mifepristone on uterine pinopodes during the implantation period
pp. 78-78(1)
Authors: Marions L.; Gemzell Danielsson K.

Elevated NK cell activity is not associated with positive test of anticardiolipin antibodies in women with recurrent spontaneous abortions
pp. 78-78(1)
Authors: Takeshita T.; Ishikawa G.; Satomi M.; Ishikawa A.; Akira S.; Kitagawa M.; Matsumoto J.; Araki T.

Orexins suppress the pulsatile secretion of luteinizing hormone in ovariectomized female rats
pp. 78-78(1)
Authors: Irahara M.; Tamura T.; Matsuzaki T.; Aono T.

The effects of human chorionic gonadotropin and interleukin-1beta on production of macrophage migration inhibitory factor by human granulosaluteal cells
pp. 78-78(1)
Authors: Minami M.; Mikuni M.; Nishihira J.; Fujimoto S.

A woman with isolated prolactin deficiency
pp. 79-79(1)
Authors: Nakae M.; Douchi T.; Yamamoto S.; Nagata Y.

A role of the niemann-pick C1 protein (NPC1)-containing compartment in the intracellular trafficking of cholesterol supporting steroidogenesis in human granulosa-lutein cells
pp. 79-79(1)
Authors: Watari H.; Strauss J.

Estrogen and progestogen levels and their receptors on the ovaries of the pinealectomized adult rats
pp. 79-79(1)
Authors: Hinoue E.; Soares J.M.; Baracat E.C.; Lang C.E.; Simoes M.J.; Oshima C.T.F.; Rodrigues de Lima G.

Endoscopic findings in pelvic tuberculosis (wadia syndrome)
pp. 80-80(1)
Authors: Wadia B.J.; Joshi N.U.; D'Souza R.; Tilwani K.P.

Endoscopic views of tuberculosis of fallopian tubes
pp. 80-80(1)
Authors: Patel N.M.; Patel C.N.

Multicentre comparative study between fluconazole and itraconazole in vulvovaginal candidiasis (VVC)
pp. 80-80(1)
Authors: Carvalho N.S.; Baract E.; Naud P.; Giraldo P.C.; Simoes J.A.; Duarte G.; Linhares I.M.; Cruz N.

Long-term results of abdominal sacral colpopexy with mersilene mesh in patients with posthysterectomy vaginal vault prolapse
pp. 80-80(1)
Authors: Kaleli S.; Ayd_nl_ K.; Erel T.; Atasu T.

Vaginal hysterectomy for non-prolapsed uterus-modified technique
pp. 80-81(2)
Author: Rajagopalan S.

Laparoscopic management of ovarian remnant syndrome using the harmonic scalpel
pp. 81-81(1)
Authors: Nezhat C.; Nezhat F.; Nezhat C.

Film: Mitra operation for cancer of the cervix extra-peritoneal pelvic lymphadenectomy ET radical vaginal hysterectomy
pp. 81-81(1)
Author: Roy Chowdhury N.

Can the New Zealand antenatal scoring system be applied in the United Kingdom?
pp. 82-82(1)
Authors: Mohamed H.; Martin C.; Smith A.; Carpenter L.; Mann C.; Haloob R.

Changes in CA130 levels depending on the form of normal placental separation (PS) of delivery and clinical significance of CA130 levels in diagnosing placental abruption (PA)
pp. 82-82(1)
Author: Shigeru M.

Complex study of pregnancy with the application of ECG, doppler ultrasonography and identification afp blood level
pp. 82-82(1)
Author: Sinauridze Z.

Criteria for prediction of antenatal fetal death in diabetic pregnant women
pp. 82-82(1)
Authors: Solonets N.; Medved V.; Gordienko I.; Romanenko E.

Dawn rule of ten complete antenatal care
pp. 83-83(1)
Authors: Shrivastava M.; Shrivastava R.; Shrivastava A.

Doppler indices from ductus venosus in I.U.G.R. fetuses between 28 and 32 weeks
pp. 83-83(1)
Authors: Lopes L.M.; Sa R.A.M.; Werner H.; Franco M.J.; Galluzzo R.N.; Pereira J.P.; Werner C.P.S.

Each woman should be very careful in making decisions over taking medications during pregnancy period
pp. 83-83(1)
Authors: Pangovska S.; Dimitrovska A.

Evaluation of mass antenatal care program of Delhi
pp. 83-83(1)
Authors: Agarwal N.; Yadav P.

Intrauterine growth retardation as a side effect of high paracetamol doses
pp. 83-84(2)
Authors: Burdan F.; Czekierdowski A.; Wyskiel M.

Lipin in comlex therapy of hypoxia in pregnants suffering from diabetes mellitus
pp. 84-84(1)
Authors: Lutsik V.; Akimova I.; Govorukha I.

Maternal and neonatal serum leptin levels in normal and diabetic pregnant egyptian women
pp. 84-84(1)
Authors: El-Adawy A.; Ibrahim M.; Gohar O.; El-Aini K.

Nitric oxide concentrations in feto-placental circulation in pregnant women with chronic intrauterine infection
pp. 84-84(1)
Authors: Zelynsky A.; Manasova G.

Partial trisomy 12g15...q22
pp. 84-84(1)
Authors: Yilmaz Z.; Erman-Akar M.; Ceylaner S.; Ceylaner G.; Nabaei S.; Gokmen O.

Peculiarities of early adaptation of infants born by mothers with antiphospholipid syndrome
pp. 84-85(2)
Authors: Chaika V.K.; Demina T.N.; Batman Y.A.; Mesherinova G.V.

Pregnant women's appreciation of personal health status and attitudes to antenatal care, sickness absence and social benefits
pp. 85-85(1)
Authors: Sydsjo A.; Sydsjo G.

Prenatal diagnosis with genetic amniocentesis
pp. 85-85(1)
Authors: Choi K.Y.; Choi S.D.; Bae D.H.

Procentual decline of fetal haematocrit between fetal transfusions in alloimmunised pregnancies
pp. 85-85(1)
Authors: Ivanovic D.; Ivanovic G.; Plecas D.; Vucinic-Kontic O.; Plesinac S.; Glisic A.; Momcilov P.; Radunovic N.; Popovic M.

Recidive hydrocephaly in tunisia
pp. 85-85(1)
Author: Jaballah N.

Study with clinical management of deliveries after 41 weeks of gestation
pp. 85-86(2)
Authors: Aisaka K.; Nakagawa K.; Uesato T.; Miwa A.; Koshino T.; Ooka F.; Nishihira M.; Sadatsuki M.; Liang S.G.; Kaibara M.

Third trimester intrauterine deaths - Unavoidable risk?
pp. 86-86(1)
Authors: Major T.; Juhasz G.; Aranyosi J.; Borsos A.

Uterine blood flow waveform analysis to predict some complications occurring in the last months of pregnancy
pp. 86-86(1)
Authors: Gargiulo L.; Guerriero V.; Caserta L.; Soriano A.; Magliole A.; Nesti E.; Caserta R.; Panariello S.

Association of radiosensitivity with expression of thymidine phosphorylase (TdRPase) in cervical squamous cell carcinoma
pp. 86-86(1)
Authors: Sanezumi M.; Okada H.; Nakajima T.; Matsubara T.; Yasuda K.; Kanzaki H.

CD40 in CIN and cervical cancer: An immunohistochemical analysis revealing an intriguing expression profile
pp. 86-86(1)
Authors: Teale G.R.; Hock Y.-L.; Luesley D.M.; Young L.S.

Cervical cancer: Feasibility and preliminary results of six cases undergoing laparoscopic assisted radical vaginal hysterectomy
pp. 87-87(1)
Authors: Pinho de Oliveira M.; Carneiro de Oliveira H.; Melki L.A.

Chemotherapy in recurrent or advanced cervical cancer
pp. 87-87(1)
Authors: Gonzalez Viciedo M.; Navarro C.; Certa B.; Yazigi R.; Castilla R.; Garrido J.; Prado S.; Sutoto M.T.; Kristanto H.; Ambari E.W.

Comparison between hydroxy-urea (HU) and mytomycin-C (MMC) as chemotherapy adjuvant on radiotheraphy
pp. 87-87(1)
Authors: Sutoto M.T.; Krisntanto H.; Ambari A.W.

Conservative surgical treatment of invasive cervical carcinoma in younger women
pp. 87-88(2)
Authors: Tasic L.; Prokic N.; Antic N.; Runic S.; Rajkovic V.; Jankovic S.; Perisic Z.; Radosavljevic R.; Moskovic T.; Lukic R.; Canovic F.

Diagnosis of minimal deviation adenocarcinoma of the cervix: A reappraisal
pp. 88-88(1)
Authors: Toki T.; Ito K.; Fujii S.

Effect on hormonal therapy in patients with inoperable endometrial carcinoma
pp. 88-88(1)
Authors: Tabakman U.U.; Solopova A.G.; Chabrov A.M.; Makatsaria A.D.

Effect of local hyperthermia combined with paclitaxel on mice inoculated with U₁₄ carcinoma cells
pp. 88-88(1)
Authors: Sun Q.; Liu L.

Gynecological oncological surgery with lipectomy
pp. 88-89(2)
Authors: Oleiek A.; Wala D.; Zamlynski J.; Michalska A.; Rzempoluch J.

Hormone replacement therapy (HRT) on special conditions: Cervical neoplasia
pp. 89-89(1)
Authors: Martins F.M.; Fonseca A.M.; Cambraia C.P.P.; Chuery A.C.S.; Bagnoli V.R.; Poveda E.; Pinotti J.A.

Human papilloma virus (HPV) plasma dna in patients with cervix cancer: a potential marker of minimal residual disease
pp. 89-89(1)
Authors: Lopez-Graniel C.; Duenas A.; Carillo A.; Fresnedo L.; Hinojosa L.M.; Rojas C.; Sanchez-Navarro A.; Trejo C.; Segura B.; Lizano M.

Late recurrent carcinoma of the uterine cervix
pp. 89-89(1)
Authors: Miyagi E.; Nakayama H.; Onose R.; Kato H.; Hatta M.; Sugiura K.; Udagawa K.; Nakazawa T.; Gorai I.; Hirahara F.

Microsatellite instability is a late event in the carcinogenesis of uterine cervical cancer
pp. 89-90(2)
Authors: Nishimura M.; Furumoto H.; Kato T.; Aono T.

P53 and C-MYC expression as biological markers for poor prognosis in invasive cervical carcinoma
pp. 90-90(1)
Authors: Brenna S.; Zeferino L.; Pinto G.; Martinez E.

Phase II Study of irinotecan combined with cisplatin as neoadjuvant chemotherapy in patients with locally advanced cervical squamous cell carcinoma
pp. 90-90(1)
Authors: Imaishi K.; Sugiyama T.; Ushijima K.; Kimura T.

Polymorphism in codon 31 of p21 and cervical cancer susceptibility
pp. 90-90(1)
Authors: Lee H.P.; Kim J.W.; Roh J.W.; Park N.H.; Song Y.S.; Kang S.B.

Relationship between vascular endothelial growth factors (VEGF) and tissue hypoxia in cervical cancer
pp. 90-91(2)
Authors: Tanaka H.; Musha T.; Jinno M.; Kosuge H.; Iwashita M.; Nakamura Y.; Yasuda Y.; Nagai T.

Routine cystoscopy in staging cancer of the cervix: Is it a must?
pp. 91-91(1)
Authors: Kekre A.N.; Seshadri L.; Kekre N.

Small cell neuroendocrine tumour of the cervix
pp. 91-91(1)
Authors: Yeap M.L.; Tay E.H.; Ho T.H.

Surgical treatment for cancer of the uterine cervix with previous radiotherapy analysis of histological specimens and complications
pp. 91-91(1)
Authors: Makabe S.; Nisida A.C.T.; Pinotti J.A.; Fonseca A.M.

The clinical relevance of plasma HPV DNA in cervical cancer
pp. 91-91(1)
Author: Chen H.-J.

The role of screening of cervical carcinoma in community
pp. 91-92(2)
Author: Qian S.

A new conception of dystocia
pp. 92-92(1)
Author: Ling L.

Analysis of high cesarean rates in kerala, India - Cause for concern
pp. 92-92(1)
Authors: Paily V.P.; Vigayakumar V.

Antibiotic prophylaxis against postpartum infections in caesarean section
pp. 92-92(1)
Authors: J-Aldea M.; Branisteanu I.; Costachescu G.

Breast feeding - How much do the mothers and expectant mothers know - An overview
pp. 92-93(2)
Authors: Dutta B.; Dutta A.; Shaikhetkar R.

Cesarean section for clinical fetal distress: Limitations of clinical diagnosis in developing countries
pp. 93-93(1)
Author: Ikechebelu J.I.

Cesarean section and abruptio placentae in period from 1985 to 2000
pp. 93-93(1)
Authors: Efremovski J.; Boskovski B.; Kostadinov J.

Complications of homeostatic cesarean in HIV+ pregnant women vs.programmed cesarean in HIV-women
pp. 93-93(1)
Authors: Hermosid S.; Pesaresi M.; Terrones C.; Militano C.; Nardin J.C.; Rodriguez M.

Elective repeat cesarean section versus trial labor after previous cesarean section: A cost-effectiveness analysis
pp. 93-94(2)
Author: Garcia-Tansengco M.L.

Homeostatic caesarean section: A new surgical technique to diminish the vertical transmission
pp. 94-94(1)
Authors: Pesaresi M.; Hermosid S.; Terrones C.; Saenz Vicuna L.; Leguizamon M.

Integration of traditional birth attendants (TBAs) into modern family planning services in 2 local government areas in Nigeria
pp. 94-94(1)
Authors: Abdul I.F.; Belgore S.M.

Is there a risk of lower segment scar rupture in pregnancy after multiple cesarean section?
pp. 94-94(1)
Author: Tamale-Sali E.G.

Lactation after cesarean section
pp. 94-94(1)
Authors: Dragon I.; Gracheva T.; Saprikin V.

Non-closure of peritoneum - Randomized trial in conditions of municipal hospital
pp. 94-95(2)
Authors: Sodowski K.; Cnota W.; Marek P.-K.; Maciej B.

Perinatal outcome on postmortem cesarean section deliveries at a school hospital in Sao Paulo
pp. 95-95(1)
Authors: Mattar R.; Camano L.; Papa A.C.E.

Study of miniature quivering-type automatic lactogenic brassiere and its clinical effectiveness
pp. 95-95(1)
Author: Song Y.Y.

The exit procedure used for an infant with cervical tumor
pp. 95-95(1)
Authors: Yoshida A.; Nakayama D.; Masuzaki H.; Ishimaru T.; Fuse M.

The longitudinal hysterotomy on the current obstetrics
pp. 95-95(1)
Authors: Massonetto J.C.; Freitas Rodrigo P.d.; Santos Fernanda E.d.; Cunha Maria Luisa D.; Davoglio M.V.

Ruptura uteri during delivery six years after previous delivery with cesarean section-case report
pp. 95-95(1)
Authors: Jovcevska-Ivanovska L.; Adamova G.; Makarijoski S.; Avramovski I.

A quantitative biometrological assessment of ACNE and hormonal evaluation in young women using a triphasic low-dose oral contraceptive containing gestodene
pp. 96-96(1)
Authors: Pierard-Franchimont C.; Gaspard U.; Lacante P.; Slachmuylders P.; Pierard G.E.

Counselling before and care during medical abortion with mifepristone
pp. 96-96(1)
Authors: Fiala C.; Akinyemi L.; Laschalt B.; Safar P.

Efficacy and safety of fluoxetine in patients taking oral contraceptives
pp. 96-96(1)
Authors: Judge R.; Bell M.; Brown E.; Koke S.

Hematological and angiological aspects of oral contraception and hormonal replacement therapy
pp. 96-96(1)
Authors: Kalousek I.; Tosner J.

IUD performance after endometrial biopsy
pp. 97-97(1)
Authors: Cunha A.C.; Miranda C.R.; Wanderley M.S.; Resende C.N.

Oral contraceptives (OC) prescribing practices in urban areas of Poland
pp. 97-97(1)
Author: Lech M.M.

Preloaded inserter for levonorgestrel implants
pp. 97-97(1)
Authors: Holma P.; Haukkamaa M.; Kuukankorpi A.; Siljander M.; Simpanen A.-L.; Rauramo I.

Reliability of modern technology as aid to natural family planning for spacing pregnancy
pp. 97-97(1)
Authors: Saporosi A.; Giacchi E.; Squintani M.C.; Menini E.; Cappella A.; Brown J.B.

Reversal of sterilisation by microsurgery in srinagarind hospital
pp. 98-98(1)
Authors: Seejorn K.; Songthamwattana M.; Thailert S.; Sinawat S.

Sharing responsibility: Women, society and unsafe abortion in developing countries
pp. 98-98(1)
Author: Irfan Y.

The characteristics of abortion by request: patients in IASI region, Romania over a 10-year period (1989-1998)
pp. 98-98(1)
Authors: Socolov R.; Zenovia Pricop F.; Butureanu S.

Ultrasound assessment of the bone quality of Nigerian women using norplant contraception
pp. 98-98(1)
Authors: Sagay A.S.; Glew R.H.; Imade G.E.; Farmer S.; Madrid E.; VanderJagt D.

Why repeat abortions are still used as method of birth control in lithuania
pp. 99-99(1)
Author: Jakubcionyte R.

Comparative study of the knowledge level of ''guidance-school female students'' mothers between rurals and town of Birjand (east of Iran) on health behaviours regarding menstruation
pp. 99-99(1)
Authors: Asadi P.; Farhadian T.; Mohammadzadeh S.

Cyber-solutions for global problems: Pilot testing computer-based infection prevention training for low resource settings
pp. 99-99(1)
Authors: Barone M.; Tzanis J.; Harper P.; Levin K.; Silverman D.; Cook C.

Diabetes education in patients with type 1 DM during preconception care and pregnancy
pp. 99-99(1)
Authors: Asatiania N.; Kurashvili R.; Natsvlishvili M.; Nikoleishvili L.; Dundua M.; Shelestova E.; Chanturia T.

Motivating rural women for antenatal care-Indian perspective
pp. 99-100(2)
Author: Sali M.

Pregnancy planning among danish women
pp. 100-100(1)
Author: Rasch V.

Study of facts & awareness about adolescent health education in school-going girls in India
pp. 100-100(1)
Author: Guota S.

Teenagers and sexuality: The roles of family and school in this discovery
pp. 100-100(1)
Authors: Dib S.; Parada L.; Iossi M.; Dib F.

The education of midwives at the beginning of the new millennium
pp. 100-100(1)
Authors: Bagdany S.; Toros E.; Meszaros E.; Tamasi F.; Nyitray G.; Bartha J.T.

The impact of health education in the promotion of cervical cancer screening in developing countries
pp. 100-101(2)
Authors: Oladokun A.; Adewole I.F.; Barbarinsa I.A.

Carcinoma endometrium is diagnosed by explorative curettage of PHA for a period of one year
pp. 101-101(1)
Authors: Dimitrovska A.; Pangovska S.

Correlation between body fat distribution and steroid hormone receptor expression in endometrial carcinoma
pp. 101-101(1)
Authors: Fujie Y.; Tsuji T.; Douchi T.; Nagata Y.

Cytokeratin expression suggesting occult metastases in regional lymph nodes of endometrial cancer
pp. 101-101(1)
Authors: Yabushita H.; Shimazu M.; Hiratake K.; Yamada H.; Narumiya H.; Sawaguchi K.; Noguchi M.; Nakanishi M.

Cytology aspiration study in endometrial carcinoma diagnosis and high risk group patients detection
pp. 101-101(1)
Authors: Elnogarr E.V.; Tabakman U.U.; Ivanov A.E.; Vahturova Z.M.; Solopova A.G.

Diagnostic hysteroscopy in endometrial hyperplasia
pp. 102-102(1)
Authors: Butureanu S.; Socolov R.; Gafitanu D.; Sachelarie L.; Pricop F.

Endogenous sexual steroids and gonadotrophins in women with and without endometrial carcinoma
pp. 102-102(1)
Authors: Tadini V.; Pinto-Neto A.; Souza G.; Brenna S.

Expression of matrix metalloprotease-7 in carcinosarcoma of the uterus
pp. 102-102(1)
Authors: Tanimoto H.; Shigemasa K.; Kusumi I.; Ohama K.

Hormone replacement therapy in women with a history of endometrial cancer
pp. 102-102(1)
Authors: Bebar S.; Ursic-Vrscaj M.

Insulin secretion in women with endometrial adenomatous hyperplasia and response to Gn&unknown;-Rh agonist therapy
pp. 102-103(2)
Authors: Smetnik V.; Tchernukha G.; Staroseltseva L.

Localization of estrone sulfatase in endometrial hyperplasia and endometrial carcinoma
pp. 103-103(1)
Authors: Watanabe A.; Ishizuka Y.; Sasaki H.; Tanaka T.

Malignant lymphoma of uterus: A case report with review of literature
pp. 103-103(1)
Authors: Agrawal A.; Ofili G.; Allan T.L.; Mann B.S.

Occurrence of metastatic lymph nodes in parailiac region in endometrial carcinoma
pp. 103-103(1)
Authors: Suzin J.; Bienkiewicz A.; Gottwald L.

Photodynamic detection of endometrial cancer
pp. 103-104(2)
Authors: De Jaco P.; Ceccarini M.; Giorgio M.; Ghi T.; Del Vecchio C.; Santini D.; Bovicelli L.

Relationship between stromal edema and localization of bradykin (BRK) in uterine cancer
pp. 104-104(1)
Authors: Momomrua M.; Musha T.; Tanaka H.; Sugawara A.; Abiko I.; Watanabe Y.; Onodera J.; Takahashi K.; Iwashita M.; Nakamura Y.; Yasuda Y.; Koyama N.

Significance of the expression of vascular endothelial growth factor (VEGF) and VEGF receptors (FLT-1, KDR and FLT-4) in endometrial carcinoma
pp. 104-104(1)
Authors: Yokoyama Y.; Sato S.; Saito Y.

Sites of failure in endometrial carcinoma surgical stage IBG3 and IC treated with postoperative vaginal vault brachytherapy
pp. 104-104(1)
Authors: Ng T.Y.; Perrin L.; Nicklin J.

Successful selection of well-differentiated carcinoma of the endometrium by hysteroscopical evaluation for conservative management
pp. 104-105(2)
Authors: Iha T.; Masamoto H.; Nakayama M.; Kanazawa K.

Tumor markers serum tetranectin and CA125 in endometrial adenocarcinoma
pp. 105-105(1)
Authors: Nyholm H.; Lundstrom M.; Hogdall C.; Nielsen A.L.

Hypoxemia induce by CO₂ or helium pneumoperitoneum is a co-factor in adhesion formation in the rabbit model
pp. 105-105(1)
Authors: Molinas C.R.; Koninckx P.R.

Hysteroscopical evaluation of the midsecretory phase endometrium: A possible correlation between unfavorable appearance and early pregnancy loss after implantation
pp. 105-105(1)
Authors: Masamoto H.; Iha T.; Kanazawa K.

Laparoscopic findings in schistosomiasis of the female genital tract and pelvic tuberculosis: A comparative study
pp. 105-105(1)
Author: Badawy A.H.

Myolysis in parous women with application of Nd:YAG lasers
pp. 105-106(2)
Authors: Takkar D.; Roy K.K.; Sinha A.; Kriplani A.; Maya

Open versus classical performance of pneumoperitoneum in gynecological laparoscopic surgery. Comparison of morbidity
pp. 106-106(1)
Authors: Lopez-Iglesias M.; Kably-Ambe A.; Barron-Vallejo J.

Ovarian neoplasms are amenable to laparoscopic management
pp. 106-106(1)
Authors: Desai S.; Wadia N.

Patients' perception of pain at out patient hysteroscopy: A prospective observational study
pp. 106-106(1)
Authors: Jivrai S.; Dass M.; Panikkar J.; Brown V.

Results of endosurgical electrodestruction of uterine myoma and adenomyosis
pp. 106-106(1)
Authors: Belocerkovceva L.D.; Strizhakov A.N.; Davydov A.I.; Osadchev V.B.

The importance of surgical laparoscopy in the complex treatment of peritoneal infertility
pp. 106-107(2)
Authors: Sirbu Z.; Cernetski O.; Comedant R.; Salari O.

Two methods for treating high grade squamous lesions of uterine cervix
pp. 107-107(1)
Authors: Miranda C.R.; Miranda J.A.; Wanderley M.S.; Resende C.N.; Cunha A.C.

Urinary tract complications during laparoscopic surgery
pp. 107-107(1)
Authors: Ostrzenski A.; Radolinski B.; Ostrzenska K.M.

Analysis of 114 cases of TVH and LAVH
pp. 107-107(1)
Authors: Luo Y.F.; Lau N.V.

Sonohysterosalpingography (S-HSG) performed in women after oviducts reconstructive operations
pp. 107-107(1)
Authors: Wojcik D.; Raszcyk H.

An attempt for gene delivery of ATP7B cDNA to hepatocytes of young LEC rat by testis-mediated gene transfer
pp. 108-108(1)
Authors: Hashida E.; Ubagai T.; Sasabe Y.; Abe Y.; Nakagama H.; Kubo H.; Hirakawa S.

Expression of NK4 cDNA in ovarian cancer cells suppresses intraperitoneal dissemination and extends host survival
pp. 108-108(1)
Authors: Saga Y.; Suzuki M.; Urabe M.; Mizukami H.; Ozawa K.; Nakamura T.; Sato I.

Metrorrhagia in postmenopausis - Treatment and histopathological findings
pp. 108-108(1)
Authors: Jovcevska-Ivanovska L.; Adamova G.; Adamoska S.

New prenatal diagnosis mehod of steroid 21-hydroxylase deficiency and mutations in CYP21B gene of Japanese patients
pp. 108-108(1)
Authors: Hayashi Z.; Yamanaka A.; Suzuki S.; Sawa R.; Yoneyama Y.; Asakura Y.; Araki T.

Analysis of 38 cases of choriocarcinoma
pp. 109-109(1)
Authors: Chakrabarti B.K.; Mondal N.R.

Analytic epidemiology of epithelial ovarian cancer with a special reference to developing countries: An evidence-based analysis
pp. 109-109(1)
Authors: Fathalla M.M.F.; Foy R.

Comparison of cone margins status in high grade CIN treated by surgical cervical amputation, cold knife conization and leep and the role of frozen section examination in predicting involved margins
pp. 109-109(1)
Authors: Carvalho J.P.; Carvalho F.M.; Pereyra E.A.G.; Parellada C.I.; Schivartche P.L.; Souen J.

Correlation between shrinkage of uterine leiomyoma treated with GNRH agonist and estrogen receptor alpha gene polymorphism
pp. 109-109(1)
Authors: Tsujimura A.; Kawamura N.; Minakuchi K.; Ogita S.

Correlation between shrinkage of uterine leiomyoma treated with gnrh agonist and interstitial deletion of chromosome 7
pp. 109-110(2)
Authors: Minakuchi K.; Kawamura N.; Tsujimura A.; Ogita S.

Correlation of descriptive sonographic criteria for adnexal tumors and ovarian malignancies
pp. 110-110(1)
Authors: Ivanovic G.; Ivanovic D.; Kadija S.; Milenkovic V.; Petkovic S.V.; Radovic M.; Mirkovic L.J.

Cytokeratin 19 mRNA: A new marker for detection of metastases in lymph nodes of gynecological cancer patients
pp. 110-110(1)
Authors: Kagabu M.; Izutu T.; Kagabu T.

Diagnosis of the invasive cervical carcinoma after the conisation
pp. 110-110(1)
Authors: Kesic V.; Pantovic S.; Petkovic S.; Argirovic R.; Milenkovic V.

Diagnosis of placental insufficiency by a method of laser correlation spectroscopy (LCS)
pp. 110-110(1)
Authors: Nagornaya V.; Marichereda V.

Endometrial changes associated with tamoxifen adjuvant therapy of postmenopausal women with breast cancer: Sonographic and pathologic correlations
pp. 110-111(2)
Authors: El-Monayeri M.; Nadim A.; Abdel-Fattah I.; Abbass A.

Human papillomavirus as a predictor of patients with uterine cervical cancer
pp. 111-111(1)
Authors: Iwasaki M.; Nishikawa A.; Akutagawa N.; Fujimoto T.; Kudo R.

IGFBP-3 expression in epithelial ovarian cancer: Favorable association with clinico-pathological parameters and patient survival
pp. 111-111(1)
Authors: Fracchioli S.; Yu H.; Massobrio M.; Katsaros D.

Inhibition of proliferation and invasion in cervical cancer cells by genistein: Implication for chemoprevetion
pp. 111-111(1)
Authors: Yang Y.-C.; Yang C.; Hsu Y.-T.; Wang S.-Y.

Lipoidic cells ovarian tumor, double located, with virilization syndrom and secondary polyglobulia
pp. 111-112(2)
Authors: Marinescu B.; Marinescu I.; Tasca L.

Ovarian protection in adolescent girls treated oncologicaly by lhrh analogs. Longitudinal follow-up
pp. 112-112(1)
Authors: Teslik L.; Horejsi J.; Radvanska J.

Preoperative differentiation of ovarian tumors using support vector machine and risk of malignancy index
pp. 112-112(1)
Author: Van Trappen P.

Risk of breast cancer in infertile women
pp. 112-112(1)
Authors: Sharif H.; Kruger Kjaer S.; Olsen J.; Bock J.

Structure modifications of the vagina wall in patients with irradiated neoplasm of neck of the womb - Qualitative and quantitative experimental research
pp. 112-113(2)
Authors: Pricon F.; Crauciuc E.; Dumitrache F.; Franco D.; Iancu D.

Study of estrogen and progesterone receptors by immunohistochemistry in breast tissue adjacent to fibroadenoma of pre-menopausal women treated with tamoxifen
pp. 113-113(1)
Authors: Gebrim L.H.; Leung S.L.; Seixas M.T.; Lima G.R.; Baracat E.C.

The benign epithelial ovarian tumors and anovulation: Restoration of fertility after the operation
pp. 113-113(1)
Authors: Artyomenko V.; Zelynsky A.

The internet and gynecologic oncology: The year 2000
pp. 113-113(1)
Author: Farahaly S.A.

Uterine sarcoma - A 16 year profile
pp. 113-113(1)
Authors: Uma Devi K.; Ahuja V.K.; Bafna U.D.; Vallikad E.

Malignant monophasic angiomyolipoma of the uterus
pp. 113-114(2)
Author: Luo Y.F.

''Going for scale'' - A meaningful antenatal procedure for mothers in rural Zimbabwe
pp. 114-114(1)
Authors: Ahlberg B.M.; Mathole T.; Majoko F.; Lindmark G.

A cost-effective model for primary women's health care
pp. 114-114(1)
Authors: Pavlov V.A.; Vaslishin R.I.; Voronin K.V.; Bashtovoi V.I.; Kolobova O.V.; Gavrish L.P.; Goldberg R.; Gluch M.; Sachs B.P.

A survey of doctors' attitudes to premenstrual syndrome and its management
pp. 114-114(1)
Authors: Domonev C.; Vashisht A.; Studd J.

Assessing the implementation of the risk approach strategy by the public health personnel in Malaysia
pp. 115-115(1)
Author: Shamsuddin K.

Emergency management for operating and recovery rooms
pp. 115-115(1)
Author: O'Hanley K.

Greek aeromedical evacuations in pregnancy
pp. 115-115(1)
Authors: Chriskos V.; Georgakopoulos P.; Daglas J.

Knowledge, attitude and practice of papanicolaou smear among Brazilian women
pp. 115-115(1)
Authors: Brenna S.; Hardy E.; Zeferino L.; Namura I.

Menstrual problems in a rural West-African population
pp. 116-116(1)
Authors: Walraven G.; Ekpo G.; Scherf C.; Coleman R.; Morison L.; Harlow S.

Midwife-managed care - impact on use of health services: an area-based randomised controlled trial
pp. 116-116(1)
Author: Berglund A.

Obstetrical/gynecological management situation in a specialised hospital Bangladesh
pp. 116-116(1)
Author: Rov C.

Physician-patient dialogue
pp. 116-116(1)
Author: Fallahian M.

Picture of hospital services for obstetrical and gynecological patients in two district hospitals in Bangladesh
pp. 116-116(1)
Author: Jahan Y.

Potentially avoidable perinatal deaths in the donetsk region, Ukraine
pp. 116-117(2)
Authors: Mogilevkina I.; Bodkerer B.; Langhoff-Roos J.; Larsen S.; Lindmark G.; Orda A.

Redefining the role of tertiary care physicians
pp. 117-117(1)
Authors: Narone J.; Narone R.

The impact of group medical visits on the number of days spent after gynecological surgery
pp. 117-117(1)
Authors: Ramos I.L.; Suassuna P.; Andrade M.

The importance of the immunohistochemical and histopathological examinations for the diagnosis of disfunctional uterine bledding (DUB)
pp. 117-117(1)
Author: Raca N.

The regionalization: an opportunity for the woman in the developing countries
pp. 117-117(1)
Author: Aguilar-Jaimes N.Y.

The results of dynamic interaction between families and providers to improve the quality and coverage of maternal and newborn health serivces in Bolivia
pp. 118-118(1)
Authors: Seoane G.; Kaune V.

Health care delivery systems and policies
pp. 118-118(1)
Author: Ashwood-Smith H.

Women friendly hospital in Bangladesh
pp. 118-118(1)
Author: Nahar K.

Ambulatory managemnt of toxemia. a series of 117 patients
pp. 118-118(1)
Authors: Smaili L.; Yahyaoui M.; Mahjoub S.; Ben Hmid R.; Lebbi I.; Zouari F.

Doppler blood flow velocity waveforms in hypertensive pregnant women
pp. 119-119(1)
Author: Iovski M.

Effect of nifedipine on the motility of the human umbilical artery in vitro
pp. 119-119(1)
Authors: Yassin A.; Costa F.; Guimaraes H.; Matthes A.; Duarte G.; Cunha S.

Fetal intravascular transfusion - clinical report
pp. 119-119(1)
Authors: ilimonovic D.; Mikovic Z.; Cirovic A.; Hajric A.

For early detection of consumption coagulopathy in preeclampsia and eclampsia - platelet count may be a suitable screening test
pp. 119-119(1)
Author: Khanam N.

Hellp syndrome and postpartum corticosteroids
pp. 119-119(1)
Author: Varol F.

High risk or low risk? do pregnant women care?
pp. 119-120(2)
Authors: Simpson H.; Ashwood-Smith H.; Finye C.; Gondwe G.; Misoya K.

Indirect evaluation of the circulatory volume of the feto-placental unit.
pp. 120-120(1)
Authors: Mirkovic L.; Plecas D.; Radunovic N.; Popovic M.; Glisic A.; Milenkovic V.; Radovic M.

Influence of pregnancy on the orovalvar bioprosthesis natural history
pp. 120-120(1)
Authors: Julio Cesar M.; Daniel B.; Marcondes de A.P.A.; Antonio Fernandes M.; Enio B.; Antonio C.

Intracardiac operation with the use of cardiopulmonary bypass
pp. 120-120(1)
Authors: Aranyosi J.; Zatik J.; Major T.; Peterffy A.

Management of pregnancies with immune thrombocytopenic purpura
pp. 120-121(2)
Authors: Has R.; Ermis H.; Yildirim A.; Batukan C.; Ibrahimog L.; Buyru F.

Management of pregnancy complicated by diabetes mellitus - 4-year experience
pp. 121-121(1)
Authors: Chanturia T.; Iashvili I.; Asatiani N.; Kurasvili R.; Hod M.

Nail-patella syndrome in pregnancy
pp. 121-121(1)
Authors: Tan L.K.; Wong C.B.; Tan H.K.; Tan A.S.A.; Choong L.

Nimodipin in the management of pregnancy induced hypertension (P.I.H.)
pp. 121-121(1)
Author: Daseuota S.

Obstetrical and perinatal outcome in multiparous adolescents
pp. 121-121(1)
Authors: Pinto J.L.; Silva M.; Chinaglia M.; Oliveira N.

Pregnancy after liver transplant: 3 cases reported
pp. 121-122(2)
Authors: Carvalho N.S.; Schwarz R.S.; Thereza L.A.

Pregnancy after liver transplantation
pp. 122-122(1)
Authors: Winograd R.; Spaccevento D.; Imventarza O.; Grimoldi S.; Celotto M.; Parada O.

Pregnancy outcomes in women aged 35 and older in a tertiary level hospital of Bangladesh
pp. 122-122(1)
Author: Begum M.R.

Subdoral hemorrage, acute fatty liver, triplet gestation in a patient with hypothalamic amenorrhea
pp. 122-122(1)
Authors: Ghaffarneiad M.; Kuchakkhan M.; Kuchakkhan M.

The lipid profile of women in prolonged pregnancy
pp. 122-123(2)
Authors: Piech P.; Adamowicz R.

Toxemia of pregnancy-hematological & biochemical changes
pp. 123-123(1)
Author: Begum K.

Umbilical cord around fetal parts: prevalence, risk factors, maternal and perinatal complications
pp. 123-123(1)
Authors: Silberstein T.; Hallak M.; Eyal S.; Holcberg G.; Katz M.; Mazor M.

Value of enhanced mri in the diagnosis of placenta percreta
pp. 123-123(1)
Authors: Palacios Jaraquemadal J.M.; Bruno C.; Pesaresi M.; Hermosid S.

Can isolated postpartum zidovudine prophylaxis reduces perinatal hiv transmission?
pp. 123-123(1)
Authors: Duarte G.; Mussi-Pinhata M.M.; Cervi M.C.; Kato C.M.; Paschoini M.C.; Quintana S.M.

Causes and treatment of ob/gyn origin diffuse peritonitis
pp. 124-124(1)
Authors: Milenkovic V.; Petronijevic M.; Vrzic S.; Petkovic S.; Berisavac M.; Boskovic V.; Mirkovic L.; Kadija S.; adovic M.

Comparative study of the pathological flora in vagina and cervix of pregnant patients from three different ethnic groups in skopje
pp. 124-124(1)
Authors: Blazevski A.; Petrovska M.; Panovski N.; Stoiceva V.; Pangovska S.; Nacevska L.; Dimitrovska N.

Forecasting of the heavy forms intrauterine infection by estimation of features hormonal function feto-placental complex
pp. 124-124(1)
Authors: Tareeva T.; Antipova I.; Kuzmenko L.; Budikina T.; Bashakin N.

Inflammatory ovarian lesions verified by hysterosalpingography
pp. 124-124(1)
Authors: Nikolov B.; Sazdanovic P.; Nikolov M.

Intra-uterus infections
pp. 124-125(2)
Authors: Antonova O.L.; Chaika V.K.; Iotenko B.A.

Is C-reactive protein an accurate predictor of infection? (preliminary report)
pp. 125-125(1)
Authors: Syamsuri A.K.; Abadi A.; Marwansyah M.

Peculiarities of the course of urogenital infections in women of pre and postmenopause
pp. 125-125(1)
Authors: Chaika V.K.; Chaneli V.G.; Iotenko B.A.

Peritoneal bilharziasis and chronic pelvic pain
pp. 125-125(1)
Authors: Freitas V.; Soares J.M.; Baracat E.C.; Lang C.E.; Schor E.; Mancini S.N.; Gongalves W.J.

Reproductive tract infections among married women in upper Egypt
pp. 125-126(2)
Authors: El Said M.M.; Sallam S.A.; Mahfouz A.A.; Dabbous N.I.; El-Barrawy M.; El-Ghamry A.; Malatawy A.

Screening sexual transmitted diseases on single women candidates to abortion in a Tunisian hospital
pp. 126-126(1)
Authors: Chelli H.; Chelli D.; Zeghal D.; Souki A.; Chennoffi M.B.; Tanfous B.; Sfar E.

Simplified disposable abdominal and vulvar drapes for caesarean section in maternal HIV-1 infection
pp. 126-126(1)
Authors: Phuapradit W.; Panburana P.; Buamuenvai J.

Study of toxoplasma infection in pregnancy in Durgapur, India
pp. 126-126(1)
Author: Sabuj Sengulpta

The prevalence of rectal and genital group B streptococcus colonization screened for reproductive age turkish women
pp. 126-126(1)
Authors: Kavak Z.N.; Uzener A.; Soletir G.; Basgul A.

The role of urogenital chlamidiosis in women to infect the newborns
pp. 126-127(2)
Authors: Japarashvili N.; Sandandelidze V.

Treatment of bacterial vaginosis in pregnancy: a retrospective cohort study in a Brazilian University Hospital
pp. 127-127(1)
Authors: Camareo R.P.S.; Simoes J.A.; Cecatti J.G.

Who should be screened for bacterial vaginosis in pregnancy?
pp. 127-127(1)
Authors: Siw T.S.; Othman M.S.; Zaki N.M.

Chromosome analysis of embryos resulting from assisted reproductive technology
pp. 127-127(1)
Authors: Sasabe Y.; Nishimura T.; Shibui Y.; Ito K.; Abe Y.; Kubo H.; Hirakawa S.

Chromosome analysis of infertile couples and amniocentesis of pregnancies in art program
pp. 127-127(1)
Authors: Shibui Y.; Sasabe Y.; Nishimura T.; Ito K.; Shiokawa M.; Nakano Y.; Ikenaga K.; Masaki K.; Abe Y.; Kubo H.; Hirakawa S.; Miura K.

Clinical evaluation of one-way and round-trip transport system for art
pp. 128-128(1)
Authors: . So A.; Abe Y.; Sasabe Y.; Shiokawa M.; Shibui Y.; Hashida E.; Ito K.; Nakano Y.; Nakano H.; Ikenaga H.; Masaki K.; Suga M.; Kubo H.; Hirakawa S.; Maeda M.

Does growth hormone augmentation and a highly purified FSH superovulation stimulation regimen improve pregnancy rates in IVF?
pp. 128-128(1)
Authors: Tan L.K.; Yu S.L.

Historical review of infertility
pp. 128-128(1)
Author: Dhoreoatil B.

Human embryo is a human embryo, not a pre-embryo
pp. 128-128(1)
Authors: Avanzini S.; Colombo R.; Bompiani A.; Ferrari A.; Mancuso S.; Spagnolo A.G.; Sgreccia E.; Vignali M.

Hyperprolactinemia and infertility
pp. 128-129(2)
Authors: Organdziski V.; Jovcevska L.; Kokormanov P.; Mirkovska G.

Identification of the human sperm protein interacting with antisperm antibody in sera of infertile women
pp. 129-129(1)
Authors: Kamadal M.; Yamamoto S.; Takikawal M.; Kunimil K.; Futaki S.; Ohmoto Y.; Aono T.; Koide S.S.; Maegawa M.

Induction of ovulation by extended clomiphene citrate and (prednisone or bromocriptine) in clomiphene citrate nonresponders.
pp. 129-129(1)
Authors: Beigi A.; Zarrinkoub F.

Infertility in the cases with endometriosis
pp. 129-129(1)
Authors: Organdziski V.; Jovcevska L.; Kokormanov P.; Mirkovska G.

Inflamatory diseases of the cervix as a cause of infertility
pp. 129-130(2)
Authors: Mirkovska G.; Organdziski V.; Jovcevska L.; Kokormanov P.

Intracytoplasmic injection using sperm aspirated by percutaneous epididymis in treatment for obstructive azoospermia
pp. 130-130(1)
Authors: Xiangge M.; Yuan L.; Yi Q.; Yun-jing F.; Mei-xin Z.

IUI with short-lived spermatozoa
pp. 130-130(1)
Author: Geeta Shroff I.